Logo

European Commission Approves BAVENCIO(R) (avelumab) Plus Axiti...

DARMSTADT, Germany, and NEW YORK, October 29, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada and UK-based media-- EU approval based on JAVELIN Renal 101 trial results demonstrating significant improvement in progression-free survival with BAVENCIO in combination with axitinib compared with sunitinib--...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660